Resurrection of Oral Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: A Historical Account From Bedside to Bench to Bedside.
acute promyelocitic leukaemia
clinical applications
history
oral arsenic trioxide
pharmacokinetics
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2020
2020
Historique:
received:
09
05
2020
accepted:
22
06
2020
entrez:
28
8
2020
pubmed:
28
8
2020
medline:
28
8
2020
Statut:
epublish
Résumé
Various forms of arsenic were used in China and elsewhere for over 5,000 years. Following the initial success of intravenous arsenic trioxide (i.v. As
Identifiants
pubmed: 32850403
doi: 10.3389/fonc.2020.01294
pmc: PMC7418518
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1294Informations de copyright
Copyright © 2020 Kumana, Mak, Kwong and Gill.
Références
Blood. 1997 May 1;89(9):3487-8
pubmed: 9129058
N Engl J Med. 1998 Nov 5;339(19):1341-8
pubmed: 9801394
PLoS One. 2016 Jul 08;11(7):e0158760
pubmed: 27391027
Blood. 2001 Mar 1;97(5):1514-6
pubmed: 11222403
Intern Med J. 2012 Aug;42(8):948-52
pubmed: 22906029
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
Blood. 2001 Jul 15;98(2):266-71
pubmed: 11435292
J Biol Inorg Chem. 2018 May;23(3):313-329
pubmed: 29396610
Cancer. 2020 Jan 15;126(2):311-321
pubmed: 31714584
Lancet Oncol. 2015 Oct;16(13):1295-305
pubmed: 26384238
J Clin Oncol. 2013 Nov 20;31(33):4215-21
pubmed: 24127444
Cancer. 2019 Sep 1;125(17):3001-3012
pubmed: 31090936
Cancer. 2020 Jul 15;126(14):3244-3254
pubmed: 32365228
J Ethnopharmacol. 2011 Jun 1;135(3):595-602
pubmed: 21497649
J Hematol Oncol. 2012 Jan 24;5:1
pubmed: 22272800
Cancer. 2018 Jun 1;124(11):2316-2326
pubmed: 29579321
Blood. 2017 Mar 9;129(10):1275-1283
pubmed: 28003274
J Am Acad Dermatol. 2005 Nov;53(5):890-2
pubmed: 16243151
Lancet Oncol. 2018 Jul;19(7):871-879
pubmed: 29884593
N Engl J Med. 2013 Jul 11;369(2):111-21
pubmed: 23841729
Ann Intern Med. 2000 Dec 5;133(11):881-5
pubmed: 11103058
Ann Hematol. 2015 Mar;94(3):501-3
pubmed: 25079038
Blood. 1999 Jan 1;93(1):268-77
pubmed: 9864170
Blood. 1997 May 1;89(9):3354-60
pubmed: 9129042
J Clin Oncol. 2005 Apr 1;23(10):2396-410
pubmed: 15800332
Leukemia. 2001 May;15(5):735-41
pubmed: 11368433
Ann Hematol. 2013 Mar;92(3):417-8
pubmed: 23053177
J BUON. 2019 Nov-Dec;24(6):2583-2586
pubmed: 31983144
Blood. 2006 Jul 1;108(1):103-6
pubmed: 16514059
Blood. 2011 Dec 15;118(25):6535-43
pubmed: 21998212
Haematologica. 2020 Jun;105(6):1567-1574
pubmed: 31558670
Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4826-31
pubmed: 18344322
Arch Intern Med. 2005 May 9;165(9):1067-8
pubmed: 15883249
Leuk Res. 2008 Feb;32(2):357-8
pubmed: 17662385
Ann Hematol. 2015 Jun;94(6):1049-51
pubmed: 25519476
Acta Pharmacol Sin. 2008 Mar;29(3):296-304
pubmed: 18298894
Hong Kong Med J. 2011 Dec;17(6):507-13
pubmed: 22147326
Blood. 2008 Nov 1;112(9):3587-90
pubmed: 18703707
Blood. 2001 Aug 1;98(3):805-13
pubmed: 11468182
Cancer Chemother Pharmacol. 2007 Mar;59(4):485-93
pubmed: 16937107
Br J Haematol. 2020 Apr;189(2):269-278
pubmed: 31863602
Eur J Clin Pharmacol. 2002 Nov;58(8):521-6
pubmed: 12451429
Leukemia. 2012 Mar;26(3):433-42
pubmed: 21904379
Hematology Am Soc Hematol Educ Program. 2003;:1-13
pubmed: 14633774